Clearer adoption pathways needed for healthtech startups to scale in Asia

HEALTHTECH startups founded in Asia are making headway overseas, but the path to profitability is less clear in their hometowns.

While startups selling consumer products and solutions can grow their markets with clever marketing or discounting, startups in the healthtech space need to get buy-in from healthcare practitioners and regulatory bodies – both private and public.

Doctors need to be convinced by studies showing a solution’s efficacy, or time saved. Governments need to be persuaded that the startup’s product is safe, or effective. Insurers need to be won with evidence of cost efficiency.